Arthur Braat

Arthur Braat is a Research Staff member at Utrecht University, affiliated with the University Medical Center Utrecht (UMCU). He contributes to two key research groups: the Endocrine Oncology Research Group, focused on improving diagnostics and treatment for rare endocrine tumors in children and adults, and the Primary Liver Tumors Research Group, dedicated to advancing care for hepatocellular carcinoma and cholangiocarcinoma through interdisciplinary collaboration.

Research Focus

Braat's work centers on nuclear medicine applications in oncology, with emphasis on:

• Endocrine and liver tumors: Developing targeted therapies and diagnostic enhancements.
• Radiopharmaceutical interventions: Including radioembolization and PET/CT imaging optimization.
• Quantitative imaging: Refining metrics like SUV for pediatric oncology.

His 2025 publications predominantly explore radioembolization techniques, PET/CT advancements, and prognostic imaging markers, reflecting a consistent focus on translational nuclear medicine in oncology.

Awards and Recognition

No scientific awards or honors are documented in the provided materials.

Research Groups and Collaboration

Braat actively participates in interdisciplinary teams within UMCU's strategic programs, including:

• Endocrine Oncology Group: International collaborations for rare tumor research.
• Primary Liver Tumors Group: Integrating clinical and imaging data for liver cancer surveillance.